Primary Resistance of Viruses in Reported New Cases of HIV, 2017-2020

Wittkop L, Gunthard H, de Wolf F, Dunn D, Cozzi-Lepri A, De Luca A . Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 2011; 11(5):363-71. DOI: 10.1016/S1473-3099(11)70032-9. View

Hauser A, Hofmann A, Meixenberger K, Altmann B, Hanke K, Bremer V . Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses. PLoS One. 2018; 13(11):e0206234. PMC: 6224275. DOI: 10.1371/journal.pone.0206234. View

Naicker C, Mansoor L, Dawood H, Naidoo K, Singo D, Matten D . Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa. BMC Infect Dis. 2020; 20(1):532. PMC: 7374822. DOI: 10.1186/s12879-020-05255-5. View

Lottes M, Bremer V, Prugger C, Kollan C, Schmidt D . Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019. BMC Health Serv Res. 2022; 22(1):63. PMC: 8756633. DOI: 10.1186/s12913-021-07390-4. View